356 related articles for article (PubMed ID: 32392557)
1. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.
Tomasik J; Harrison SJ; Rustogi N; Olmert T; Barton-Owen G; Han SYS; Cooper JD; Eljasz P; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
JAMA Psychiatry; 2024 Jan; 81(1):101-106. PubMed ID: 37878349
[TBL] [Abstract][Full Text] [Related]
3. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
[TBL] [Abstract][Full Text] [Related]
4. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
5. Towards a blood-based diagnostic panel for bipolar disorder.
Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
[TBL] [Abstract][Full Text] [Related]
6. Antibody profiling of bipolar disorder using Escherichia coli proteome microarrays.
Chen PC; Syu GD; Chung KH; Ho YH; Chung FH; Chen PH; Lin JM; Chen YW; Tsai SY; Chen CS
Mol Cell Proteomics; 2015 Mar; 14(3):510-8. PubMed ID: 25540388
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
Hashimoto K
Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
[TBL] [Abstract][Full Text] [Related]
8. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
[TBL] [Abstract][Full Text] [Related]
9. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.
Girshkin L; Matheson SL; Shepherd AM; Green MJ
Psychoneuroendocrinology; 2014 Nov; 49():187-206. PubMed ID: 25108162
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Nondepleted Plasma Multiprotein-Based Model for Discriminating Psychiatric Disorders Using Multiple Reaction Monitoring-Mass Spectrometry: Proof-of-Concept Study.
Shin D; Lee J; Kim Y; Park J; Shin D; Song Y; Joo EJ; Roh S; Lee KY; Oh S; Ahn YM; Rhee SJ; Kim Y
J Proteome Res; 2024 Jan; 23(1):329-343. PubMed ID: 38063806
[TBL] [Abstract][Full Text] [Related]
11. AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort.
Salvetat N; Checa-Robles FJ; Delacrétaz A; Cayzac C; Dubuc B; Vetter D; Dainat J; Lang JP; Gamma F; Weissmann D
J Affect Disord; 2024 Jul; 356():385-393. PubMed ID: 38615844
[TBL] [Abstract][Full Text] [Related]
12. Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder.
Richards AL; Cardno A; Harold G; Craddock NJ; Di Florio A; Jones L; Gordon-Smith K; Jones I; Sellers R; Walters JTR; Holmans PA; Owen MJ; O'Donovan MC
JAMA Psychiatry; 2022 Oct; 79(10):1032-1039. PubMed ID: 36044200
[TBL] [Abstract][Full Text] [Related]
13. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
[TBL] [Abstract][Full Text] [Related]
14. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
[TBL] [Abstract][Full Text] [Related]
15. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
[TBL] [Abstract][Full Text] [Related]
17. Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study.
Chang M; Womer FY; Edmiston EK; Bai C; Zhou Q; Jiang X; Wei S; Wei Y; Ye Y; Huang H; He Y; Xu K; Tang Y; Wang F
Schizophr Bull; 2018 Jan; 44(1):65-74. PubMed ID: 29036668
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
Pu J; Liu Y; Gui S; Tian L; Xu S; Song X; Zhong X; Chen Y; Chen X; Yu Y; Liu L; Zhang H; Wang H; Zhou C; Zhao L; Xie P
Psychiatry Res; 2020 Oct; 292():113319. PubMed ID: 32717712
[TBL] [Abstract][Full Text] [Related]
20. Discriminating bipolar depression from major depressive disorder with polygenic risk scores.
Liebers DT; Pirooznia M; Ganna A; ; Goes FS
Psychol Med; 2021 Jul; 51(9):1451-1458. PubMed ID: 32063240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
